Once it was not released in market I suspected it would not be good. And it was not.
The problem with this 4c is it cites the covid pandemic as the reason for sales problems but Phillips has been telling us since this began that the 1A was gong to benefit and it would drive sales. This has not happened. It may have impacted the sale of the newer products but we were told the 1A was going to benefit, especially in China.
The positive is its a very tightly held stock, really does trade around the margins so it should hold up OK as those who own tend to be true believers.
The science has never really been the issue, they just cannot sell.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable